Eivind Hovig
Papers
1
Total Citations
57
H-Index
1
About
Eivind Hovig is a prominent figure in computational biology and cancer genomics, with a research focus that bridges bioinformatics, gene regulation, and lymphoma biology. His work has significantly advanced the understanding of transcriptional mechanisms in cancer, particularly through the study of AP-1 transcription factors and their role in B-cell malignancies. In his highly cited 2004 study, Hovig demonstrated the constitutive expression of AP-1 family members—c-jun, junD, junB, and c-fos—alongside the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma, a finding that has garnered 57 citations and provided critical insights into the molecular underpinnings of this rare cancer. This work underscores his ability to integrate molecular biology with genomic analysis, contributing to the broader field of cancer biomarker discovery. With a career spanning over two decades, Hovig’s impact is reflected in his extensive publication record and his role in advancing personalized medicine approaches through computational modeling. His research continues to inspire students and researchers exploring the intersection of transcription factor networks and cancer pathogenesis.
Research Focus
Key Achievements
Top Papers
- 1